---
document_datetime: 2023-09-21 17:40:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zessly-epar-all-authorised-presentations_en.pdf
document_name: zessly-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0078153
conversion_datetime: 2025-12-22 09:29:34.362535
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/18/1280/001   | Zessly   | 100 mg   | Powder for concentrate for                                             | Intravenous use   | vial (glass)   | 1 vial   |
|--------------------|----------|----------|------------------------------------------------------------------------|-------------------|----------------|----------|
| EU/1/18/1280/002   | Zessly   | 100 mg   | solution for infusion Powder for concentrate for solution for infusion | Intravenous use   | vial (glass)   | 2 vials  |
| EU/1/18/1280/003   | Zessly   | 100 mg   | Powder for concentrate for solution for infusion                       | Intravenous use   | vial (glass)   | 3 vials  |
| EU/1/18/1280/004   | Zessly   | 100 mg   | Powder for concentrate for solution for infusion                       | Intravenous use   | vial (glass)   | 4 vials  |
| EU/1/18/1280/005   | Zessly   | 100 mg   | Powder for concentrate for solution for infusion                       | Intravenous use   | vial (glass)   | 5 vials  |